Early uptake for oral semaglutide proves rapid relative to injectables

Дата публикации: 22-10-2026 22:20:15

Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight management therapies, according to a study published online Oct. 13 in Annals of Internal Medicine.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	<![CDATA[Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study]]>	0	15.78	05-10-2026
2	Semaglutide in pillola, via libera in Europa al primo farmaco orale per la gestione del peso	0	4.94	16-07-2026
3	Scientists discover why Ozempic and Wegovy weight loss eventually plateaus	0	12.8	25-05-2026
4	Time-Dependent Effects of GLP-1 Receptor Agonists on Weight Loss: A Systematic Review and Meta-Analysis of Phase 3 Trials [version 1; peer review: awaiting peer review]	0	13.63	08-08-2026
5	New GLP-1 pill delivers up to 12% weight loss in 36 weeks	0	11.64	10-08-2026
6	Hope for new low cost slimming pill as daily tablet beats oral semaglutide in trial	0	7.86	26-02-2026
7	Ozempic & Wegovy: Tablette als Alternative? Studie zeigt beeindruckenden Effekt	0	7.03	19-08-2026
8	New weight loss pill beats oral Ozempic in major trial	0	9.35	07-07-2026
9	GLP-1 boom in China, India, Brazil could create $22bn market by 2035, J.P. Morgan says	0	12.32	23-10-2026
10	Длительный прием «Оземпика» возвращает аппетит, не увеличивая потребление калорий	0	7.87	24-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.86. Источник: medicalxpress.com.